Drug Interaction Report
4 potential interactions and/or warnings found for the following 2 drugs:
- teplizumab
- Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid)
Interactions between your drugs
tetanus toxoid teplizumab
Applies to: Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid), teplizumab
If you are currently receiving or have received teplizumab within the past six weeks, you should talk to your doctor before receiving tetanus toxoid. Teplizumab may cause you to have a reduced response to the vaccine, and your doctor may want to delay vaccination to give your body time to recover from the effects of teplizumab therapy. If you have recently been vaccinated with tetanus toxoid, your doctor may choose to postpone treatment with teplizumab for 2 weeks. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
diphtheria toxoid teplizumab
Applies to: Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid), teplizumab
If you are currently receiving or have received teplizumab within the past six weeks, you should talk to your doctor before receiving diphtheria toxoid. Teplizumab may cause you to have a reduced response to the vaccine, and your doctor may want to delay vaccination to give your body time to recover from the effects of teplizumab therapy. If you have recently been vaccinated with diphtheria toxoid, your doctor may choose to postpone treatment with teplizumab for 2 weeks. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
pertussis, whole cell teplizumab
Applies to: Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid), teplizumab
If you are currently receiving or have received teplizumab within the past six weeks, you should talk to your doctor before receiving pertussis, whole cell. Teplizumab may cause you to have a reduced response to the vaccine, and your doctor may want to delay vaccination to give your body time to recover from the effects of teplizumab therapy. If you have recently been vaccinated with pertussis, whole cell, your doctor may choose to postpone treatment with teplizumab for 2 weeks. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
haemophilus b conjugate (HbOC) vaccine teplizumab
Applies to: Tetramune (diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid), teplizumab
If you are currently receiving or have received teplizumab within the past six weeks, you should talk to your doctor before receiving haemophilus b conjugate (HbOC) vaccine. Teplizumab may cause you to have a reduced response to the vaccine, and your doctor may want to delay vaccination to give your body time to recover from the effects of teplizumab therapy. If you have recently been vaccinated with haemophilus b conjugate (HbOC) vaccine, your doctor may choose to postpone treatment with teplizumab for 2 weeks. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Lantus
Lantus is a long acting form of insulin used to treat type 1 or type 2 diabetes. Learn about side ...
Tresiba
Tresiba (insulin degludec) is used to treat diabetes mellitus. Includes Tresiba side effects ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Basaglar
Basaglar (insulin glargine) is a long-acting insulin that is used to improve blood sugar control in ...
Humalog
Humalog (insulin lispro) is used to treat type 1 (insulin-dependent) diabetes in adults. Includes ...
Levemir
Levemir (insulin detemir) is a long acting insulin used to treat diabetes in adults and children ...
Novolog
NovoLog is a fast-acting insulin used to treat diabetes to control blood sugar levels in adults and ...
Semglee
Semglee (insulin glargine-yfgn) is used for type 1 and type 2 diabetes mellitus. Includes Semglee ...
Toujeo SoloStar
Toujeo (insulin glargine) is an injection used to treat type 1 or type 2 diabetes. Includes Toujeo ...
Lantus SoloStar
Lantus SoloStar is used for diabetes, type 1, type 2 diabetes
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.